Board & Management

Anders Essen-Möller, Chairman. Born in 1941. M.Sc. Founder and former CEO of Diamyd. Anders Essen-Möller also founded Synectics Medical AB, which was sold to Medtronic Inc. in 1996. Other Assignments: Member of the board of Mertiva AB. Holdings in Diamyd Medical as of April 30, 2013: 479 292 A shares and 187 741 B shares.

Maria-Teresa Essen-Möller, Board Member. Born in 1970. M.Sc. in Business Administration. Account Manager at Creuna AB. Maria-Teresa Essen-Möller was Head of Investor Relations and Corporate Communications Diamyd 1997-1999. Other Assignments: Member of the boards of Creative Antibiotics AB and Stiftelsen Adolf Fredriks and Gustav Vasa Barnkrubba. Holdings in Diamyd Medical as of April 30, 2013: 12 000 B shares.

Erik Nerpin, Independent Board Member. Born in 1961. Lawyer, partner in the law firm Kilpatrick Townsend Stockton in Stockholm, Sweden. Specialized in Corporate Law and Corporate Finance. Other assignments: Chairman of the Board of Cassandra Oil AB and Kancera AB. Board member of Aqeri Holding AB, HCH Sweden Holding AB, Igrene AB, Blasieholmen Investment Group AB, Otirol Art AB, European Resolution Capital i Sverige AB and the Swedish subsidiaries of Lundin Mining Corp. and Coastal Contacts Inc. Holdings in Diamyd Medical as of April 30, 2013: 0

Peter Zerhouni, President and CEO. Born in 1972. M.Sc. in Biology and a B.Sc. in Economics & Business Administration from Lund University and UC Berkeley. From 1999 to 2006 Peter Zerhouni held various positions at ING Bank in Brussels and Amsterdam. Peter Zerhouni joined Diamyd in 2006 and was appointed President in 2011. Holdings in Diamyd Medical AB as of April 30, 2013: 0 t in 2011.

Erika Hillborg, Senior Director Clinical Development. Born in 1967. M.Sc. in Biomedicine from the Karolinska Institute in Stockholm, with a Science Journalism degree from Uppsala University. Erika Hillborg joined Diamyd in 2006. Holdings in Diamyd Medical AB as of April 30, 2013: 0

Anna Styrud, Chief Financial Officer. Born in 1961. B.Sc. in Business Administration from Uppsala University. Previous experience includes Group Treasurer of Vasakronan and various positions within finance, treasury and control at Fläkt AB and National Board of Public Building. Anna Styrud joined Diamyd in 2010. Holdings in Diamyd Medical AB as of April 30, 2013: 500 B shares.